Moderna (MRNA) insider trading

By person

12 insiders · 24 transactions

2,059×

Stéphane Bancel holds 2,059 times base salary in stock. $3.45B of shares against $1.68M in salary for 2025.

Salary from the company's own proxy. The shares are what Stéphane Bancel last reported holding, valued at $220.72, the price Common Stock was last bought or sold at on the open market here, on 15 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Stephen Hoge

President

—

$45.45M (9) scheduled

−$45.45M

1,792,614

0.4490%

$395.67M

+12.1%

Stephane Bancel

Chief Executive Officer

—

$28.72M (4) scheduled

−$28.72M

15,650,946

3.92%

$3.45B

+7.7%

James M Mock

Chief Financial Officer

—

$4.69M (2) scheduled

−$4.69M

60,125

0.0151%

$13.27M

+532.6%

Shannon Thyme Klinger

Chief Legal Officer

—

$1.39M (3) scheduled

−$1.39M

81,340

0.0204%

$17.95M

+326.1%

Noubar Afeyan

Director

—

$1.14M (2) scheduled

−$1.14M

3,924

0.0010%

$866.11K

0.0%

Abbas Hussain

Director

—

$278.86K (2) scheduled

−$278.86K

12,066

0.0030%

$2.66M

—

Paul Sagan

Director

—

312,027

0.0782%

$68.87M

+11.3%

Francois Nader

Director

—

32,781

0.0082%

$7.24M

+59.1%

Elizabeth G Nabel

Director

—

19,317

0.0048%

$4.26M

+817.7%

Sandra Horning

Director

—

18,585

0.0047%

$4.10M

+1,254%

David M. Rubenstein

Director

—

9,643

0.0024%

$2.13M

—

Elizabeth E Tallett

Director

—

4,761

0.0012%

$1.05M

+577.2%

Moderna

What the insiders did Scheduled selling only

By person